COMPOUNDS
The present invention provides compounds which are selective allosteric inhibitors of TMLR, TMLRCS, LR, LRCS containing EGFR mutants, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances.
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
27.03.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention provides compounds which are selective allosteric inhibitors of TMLR, TMLRCS, LR, LRCS containing EGFR mutants, their manufacture, pharmaceutical compositions containing them and their use as therapeutically active substances. |
---|---|
Bibliography: | Application Number: MY2019PI07060 |